期刊文献+

3种不同血管紧张素受体阻滞剂类药物对早期糖尿病肾病治疗效果分析 被引量:5

The analysis of therapy effict about different angiotensin receptor blocker drugs on early diabetic nephropathy
下载PDF
导出
摘要 目的分析3种不同血管紧张素受体阻滞剂类药物治疗早期糖尿病肾病的疗效。方法将90例早期糖尿病肾病患者随机分为A、B、C3组,每组30例。A组患者采用缬沙坦进行治疗,B组患者采用伊贝沙坦进行治疗,C组患者采用替米沙坦进行治疗,对比3组临床疗效。结果经治疗,3组患者的病情均得到了一定程度的改善,A、C组总有效率均为90.0%,B组总有效率为93.3%。结论在治疗早期糖尿病肾病的过程中,采用不同血管紧张素受体阻滞剂类药物治疗均可明显提高临床疗效,其中采用伊贝沙坦治疗的效果最好,值得临床推广应用。 Objective To analysis the effect of three kinds of angiotensin receptor blocker drugs on early diabetic nephropathy.Methods 90 cases patients with early diabetic nephropathy were randomly divided into A group、B group、C group,each of 30 cases.A group was given valsartan,B group was given irbesartan,C group was given telmisartan.After treatment,compared the effect of three groups.Results After treatment,the three groups of the patient's conditionhad been improved to some extent.The total effective rate of A、C group were 90.0%,B group was 93.3%.Conclusion Angiotensin receptor blocker class of drugs can improve the clinical efficacy of early diabetic nephropathy,and the most effectively is irbesartan.
作者 陈勇
出处 《临床合理用药杂志》 2013年第1期28-29,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 糖尿病肾病 早期 缬沙坦 伊贝沙坦 替米沙坦 Diabetic nephropathy early Valsartan Irbesartan Telmisartan
  • 相关文献

参考文献6

二级参考文献25

  • 1刘必成,马坤岭.血管紧张素Ⅱ受体拮抗剂在非糖尿病性肾病中临床应用的研究进展[J].现代医学,2006,34(1):1-4. 被引量:1
  • 2Lewis EJ, Lewis JB. Treatment of diabetic nephropathy with angiotensin Ⅱ receptor antagonist[J]. Exp Nephrol, 2003,7 (1):1-8
  • 3Bums KD. Angiotensin Ⅱ and its receptors in the diabetic kidneg[J]. Am J Kidney Dis,2000,36(3) :449 - 467
  • 4Haffner S M, Lehto S, Ronnemaa T, ct al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infection [J]. N Engl J Med, 1998,339(4) : 229-234.
  • 5Parving H H, Lehnert H, Brochner J, et al. The effect of irbesartan on development of diabetic Nephropat-hy in patients with type 2 diabetes [J]. N Engl J Med,2001,345(12) :870-878.
  • 6Parring H H. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment [ J ]. Diabetologia, 1998,41 ( 7 ) : 745-759.
  • 7Manuel P. Therapeutic measures in proteinufic nephropathy [J]. Kidney Internatonal, 2005,68( 1 ) : 137-141.
  • 8Mizuiri S, Yoshikawa H, Tanegasshima M, et al. Renal ACE immunoohisttochemical localization in NIDDM patients with nephropathy [J]. Am J Kiney Dis, 1998,31 (2) : 301-307.
  • 9Radeke HH, Meier B, T opley N, et al. Interleukin-1 alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells[J]. Kidney Int, 1990,37(2):767.
  • 10Hollenberg NK, Stevanovic R, Agarwal A, et al. Plasma aldosterone concentration in the patientwith diabetes mellitus [J]. Kidney Int,2004;65:1435-1439.

共引文献10

同被引文献38

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部